10th

ANNUAL

EUROPEAN LIFE SCIENCES CEO FORUM & EXHIBITIONfor Partnering and Investing in Biotech & Pharma Industry

6 - 7 MARCH 2017Hilton Zurich Airport Hotel

Registration & Co�ee

Welcome Speech by Leonard Sachs, Managing Director, Sachs Associates Ltd.

Bio-Pharma Industry Overview for 2017: Challenges and Opportunities Panel - Room Panorama AChaired by:Stephanie Léouzon, Partner and Head of Torreya Partners Europe, Torreya Partners (Europe) LLPPanelists:Adam Kostyál, Senior Vice President, NASDAQ OMX Jim Philips, CEO, Midatech Pharma PLCMark Altmeyer, President and Chief Commercial O�cer, Axovant Sciences Ltd.Sarah Holland, VP, BD&L Business Partner, GEM Business Unit, Sano�Sascha Alilovic, VP, Head of Corporate Finance & Corporate Development, MorphoSys AG

07:15

08:20

08:10

Day One, 6 March 2017

“Drug Chess - Planning a Few Moves Ahead of the Competition” by Peter Kolchinsky, Portfolio Manager and Managing Director, RA Capital - Room Panorama A 09:05

Private Equity & VC Panel - Room Panorama ACo-Chaired by:Markus Goebel, Managing Director, Novartis Venture FundMarkus Hosang, General Partner, BioMedPartners AGPanelists:Arthur Franken, Partner, Gilde Healthcare PartnersEric de La Fortelle, Venture Partner, Seventure PartnersLionel Carnot, Managing Director, Bay City CapitalMaciek Drozdz, Principal, Venture Investments, London Innovation Center, Johnson & Johnson InnovationPaul Hermant, Partner, Bird & Bird LLPThierry Chignon, Senior Partner, Merieux Developpement

09:30

Co�ee Break10:30

th th

th Wi-Fi Access InformationNetwork Name: Hilton MeetingsAccess Code: zrhhi1703

French BioPharma Investment Panel - Room Panorama ACo-Chaired by:Cedric Moreau, Managing Director - Head of Healthcare, Oddo & CieChristophe Bourrilly, Managing Director, KRONOS ADVISORSPanelists:Aaron Bensimon, CEO, Genomic Vision Chris Maggos, Managing Director, Europe, LifeSci AdvisorsMarc Le Bozec, Fund Manager, Pluvalca BiotechRemi Droller, Managing Partner, Kurma PartnersThibaut Roulon, Investment Director, Life Sciences, Bpifrance

10:45

Vaccines & Infectious Diseases Panel - Room Panorama CChaired by:Florian Schödel, Owner, Philimmune, LLCPanelists:Bill Hearl, President & CEO, Immunomic Therapeutics, Inc.Geo� Dow, CEO, 60 Degrees Pharmaceuticals, LLCNicholas Benedict, CEO, Allecra Therapeutics GmbHPierre Courteille, CCO and VP BD, ABIVAXWouter Latour, CEO, Vaxart, Inc.

10:45

Platform & Enabling Technologies Panel 1 - Room Panorama AChaired by:Peter Dudek, Principal, Wellington PartnersPanelists:Alexandra Richardson, Head of BD, Clayton Biotechnologies, Inc.Cedric Ververken, CEO, Confo TherapeuticsMartin Welschof, CEO, Opsona Therapeutics Ltd.Michael Motz, CEO, MAB BiopharmaceuticalsNanna Luneborg, Principal, Novo VenturesYochi Slonim, Co-Founder & CEO, Anima Biotech Ltd.

11:30

CNS Panel 1 - BD&L - Room Panorama CChaired by:Jennifer Laird, Senior Director, Search & Evaluation, Eli Lilly & CompanyPanelists:Anja König, Managing Director, Novartis Venture FundFrançois Conquet, CEO, Prexton TherapeuticsLaura Corradini, Deputy Global Head, CNS BD&L, Boehringer Ingelheim GmbHSo�a Ioannidou, Investment Director, Life Sciences, Edmond de Rothschild Investment Partners

11:30

Platform & Enabling Technologies Panel 2 - Gene Editing & Cell TherapyRoom Panorama ACo-Chaired by:Alain Vertes, Director EU Section, Alliance for Regenerative MedicineKatya Smirnyagina, Partner, Capricorn Venture Partners NVPanelists:Daniel Gau, Head of BD, COO, Unicyte AGDavid Venables, CEO, Synpromics Ltd.Dirk Reyn, CEO, eTheRNA immunotherapies NVStephane Boissel, CEO, TxCell SA

12:15

CNS Panel 2 - Advanced Therapeutics - Room Panorama CCo-Chaired by:Laurence Barker, Dementia Discovery Fund CBO, SV Life SciencesNaveed Siddiqi, Partner, Edmond de Rothschild Investment PartnersPanelists:Brad Margus, CEO, CerevanceKjell Stenberg, CEO, Cyxone ABLaurent Nguyen, CEO, Sensorion SATim Dyer, CEO, Addex Therapeutics Ltd.

12:15

Presentation Track A - Room BerneModerated by: Sven Rohmann, Suenos Advisors Est.

OSE Immunotherapeutics - [OSE: EN]

Opsona Therapeutics Ltd.

Oxford BioMedica PLC - [LON: OXB]

ThromboGenics NV - [EBR: THR]

Cyxone AB

SOM Biotech

Oncomatryx Biopharma, S.L.

Networking Lunch - served in Registration Room and Horizon Restaurant13:00

Space for Notes: ________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

10:45

11:00

11:15

11:30

11:45

12:00

12:15

Presentation Track B - Room Panorama CModerated by: Bob Pooler, valuationLAB AG

Presentation Track C- Room BerneModerated by: Hans Herklots, Capricorn One

TxCell SA - [EPA: TXCL]14:00

Genomic Vision - [EPA: GV]14:15

Anima Biotech Ltd.14:30

Syna�x BV14:45

60 Degrees Pharmaceuticals, LLC15:00

MyCartis15:15

Eligo Bioscience15:30

eTheRNA immunotherapies NV15:45

Curetis N.V. - [CURE: NA]14:00

NetScienti�c PLC - [LON: NSCI]14:10

TaiwanJ Pharmaceuticals - [6549: TT]14:20

MAB Biopharmaceuticals14:30

Mymetics Corporation - [OTCMKTS: MYMX]14:40

Medicortex Finland Oy14:50

Allecra Therapeutics GmbH15:00

Orbit Discovery15:10

DATA 4 ACTIONS, Inc. – TOWWERS Program15:20

Greenbone Ortho SRL15:30

Lytix Biopharma AS15:40

Immunic AG15:50

Co�ee Break16:00

Space for Notes: __________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

Acesion Pharma ApS16:15

Acticor Biotech SAS16:25

CardioRenal SAS16:35

InterAx Biotech AG16:45

Strekin AG16:55

Origenis GmbH17:05

Timmune Biotech, Inc.17:15

20Med Therapeutics B.V.17:25

Autoimmune & In�ammatory Diseases Panel - Room Panorama ACo-Chaired by:Jasper Bos, VP and Head of Healthcare Fund, Merck Ventures B.V.Markus Kalousek, Global BD&L S&E Franchise Head (I&D), Novartis Pharma AG Panelists:Adam Houghton, Senior Director & Head, Immunology Search and Evaluation, AbbVie, Inc.Daniel Vitt, CEO, Immunic AGFabian Büller, Director, New Ventures, Johnson & Johnson Innovation, LLCJosep M. Casanovas, Head of Immuno-Dermatology, External Innovation & Licensing, Almirall S.A.Thomas Hanke, EVP In�ammation and Immunology, Evotec International GmbH

16:15

Diagnostics & Biomarkers Panel - Room Panorama AChaired by:Beat Merz, Managing Director, Rockport Venture PartnersPanelists:Claire Huguet, Head of Biomarker Services, Randox Laboratories Ltd.Joris Schuurmans, CEO, MyCartisMiro Venturi, Global Head - Diagnostics Biomarkers, F. Ho�mann-La Roche Ltd.Oliver Schacht, CEO, Curetis N.V.Tom Gibbs, Director Investments, Alliances & Licensing, Debiopharm Innovation Fund

17:00

Networking Reception17:45

End of Reception & Day One 20:00

Presentation Track F - Room BerneModerated by: Subhasis Roy, Sirius Healthcare Partners

Presentation Track E - Room Panorama CModerated by: Jørgen Thorball, XOventure GmbH

ABIVAX - [EPA: ABVX]16:15

Vaxart, Inc. 16:30

Immunomic Therapeutics, Inc.16:45

Hookipa Biotech AG17:00

Vaximm AG17:15

Invectys SA17:30

10th EUROPEAN LIFE SCIENCES CEO FORUM & EXHIBITIONfor Partnering and Investing in Biotech & Pharma Industry

6 - 7 MARCH 2017Hilton Zurich Airport Hotel

th th

ANNUAL

Registration & Co�ee08:00

Day Two, 7 March 2017

Bio-Pharma DealMaking Outlook for 2017 Panel - Room Panorama AChaired by:Fintan Walton, CEO, PharmaVentures Ltd.Panelists:Alexander Breidenbach, Director, Global BD Neuroscience, F. Ho�mann - La Roche Ltd.Ben Thorner, Senior Vice President and Head of BD&L, MSDEmilio Erazo-Fischer, Associate Director of Global Oncology BD&L, Boehringer Ingelheim GmbHFrank Grams, VP, Global Head R&D Alliance Management, Sano�Nathalie ter Wengel, European Head External R&D and Innovation, P�zer, Inc.Olivier Crauk, Director Corporate BD, IpsenPatrick Benz, Senior Director Alliance Management, Johnson & Johnson

08:30

“VC Investment Decisions – Market Access Considerations and Important Value Driver” by Thomas Hasmann, VP Market Access, HighPoint Solutions - Room Panorama A 10:15

Oncology DealMaking Panel - Room Panorama ACo-Chaired by:David Colpman, Director, Colpman Consulting Ltd.Esteban Pombo-Villar, Independent ConsultantPanelists:Allison Jeynes-Ellis, CEO, Avillion LLPCatherine Pickering, Head of Oncology & Immuno-Oncology Licensing, Merck KGaAJason Slingsby, Head of BD, Oxford BioMedica PLCJohn Haurum, CEO, F-Star Biotechnology Ltd.Laurent Audoly, Managing Partner and Founder, Pierre Fabre Fund for InnovationStephen Sands, BD&L Director, F. Ho�mann-La Roche Ltd.Thilo Schroeder, Partner, Nextech Invest Ltd.

09:15

Co�ee Break10:35

10th EUROPEAN LIFE SCIENCES CEO FORUM & EXHIBITIONfor Partnering and Investing in Biotech & Pharma Industry

6 - 7 MARCH 2017Hilton Zurich Airport Hotel

th th

th

ANNUAL

Wi-Fi Access InformationNetwork Name: Hilton MeetingsAccess Code: zrhhi1703

“Partnering with Novartis” by Nigel Sheail, Head of Business Development and Licensing, Novartis10:50

Clayton Biotechnologies, Inc.11:10

Confo Therapeutics11:20

Synpromics Ltd.11:30

[Empty]11:40

Sutura Therapeutics Ltd.11:50

Unicyte AG12:00

Novassay SA12:10

Novaremed Ltd.12:20

Thermosome GmbH12:30

IO Biotech ApS12:40

Advances in Immuno-Oncology Therapeutics Panel Room Panorama ACo-Chaired by:Chris Sheldon, Head, Oncology Search & Evaluation, AstraZeneca François Thomas, President and Managing Partner, Inserm Transfert InitiativePanelists:Heinz Lubenau, COO, Vaximm AGJörn Aldag, CEO, Hookipa Biotech AGJuergen Gamer, VP BD, Apogenix AGJulia Berretta, VP BD and Strategic Planning, Cellectis SAMagnus Jaderberg, CMO, Targovax ASATibor Papp, Senior Director, BD, Shire Pharmaceuticals

11:10

Pharma Innovation: Role of Academic Medical Centres and Foundations Panel - Room Panorama ACo-Chaired by:Georgios Trichas, Senior Business Analyst, Wellcome Trust, Innovations DivisionHolger Schwarz, Director, Global Head of Search & Evaluation Discovery Technologies Biopharma, Global Research & Development, External Innovation, Merck KGaAPanelists:Carolyn Porter, Deputy Head of Technology Transfer, Oxford University InnovationJutta Roth, Head of Strategic Development, Queen Mary University LondonMaria Bobadilla, Senior Director, Partnering Innovation, F. Ho�mann - La Roche Ltd.Mark Farmery, Senior Manager, BD, Karolinska Institutet Innovations ABShiva Dustdar, Head of Division, Innovation Finance Advisory, European Investment BankSimon Blake, Senior Director, Scienti�c Licensing for Immunology, Johnson & JohnsonYilmaz Mahshid, Investment Manager, Industrifonden

12:10

Presentation Track H - Room BerneModerated by: Wilder Fulford, The Fulford Group

Presentation Track G - Room Panorama CModerated by: Jørgen Thorball, XOventure GmbH

Realm Therapeutics, Inc.11:10

Sensorion SA - [EPA: ALSEN]11:25

Addex Therapeutics Ltd. - [ADXN: SW]11:40

Purdue Pharma L.P.11:55

[Empty]12:10

Apogenix AG12:40

Targovax ASA - [OSE: TRVX]12:25

Networking Lunch - served in Registration Room and Horizon Restaurant13:00

Space for Notes: __________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

BaseLaunch Presentation - Room Panorama ASpeaker:Alethia De Leon, Managing Director, BaseLaunchQ&A with:Anja König, Managing Director, Novartis Venture FundFabian Büller, Director, New Ventures, Johnson & Johnson Innovation, LLCNathalie ter Wengel, European Head External R&D and Innovation, P�zer, Inc.

14:00

Rising Stars: Start-Up Showcase, Single Track of 3 minute presentations - Room Panorama A Moderated by: Ulrich Mühlner, Founder & Managing Director, GrowthCube Partners, LLCRao Movva, Novartis Distinguished Scientist (retired) & Currently Independent Pharma and Biotech Advisor

14:20 1. ABBA Therapeutics2. Elthera AG3. MyeloPro Diagnostics and Research GmbH4. SUINCol5. PanCryos6. Anjarium Biosciences AG7. PhytoSwiss Pharma

Seed Companies Investor Roundtable - Room Panorama ACo-Chaired by:Christina Trojel, Senior Investment Associate, Novo SeedsHakan Goker, Senior Investment Director, Merck Ventures B.V.Panelists:Dirk Kersten, Managing Director, INKEF Capital BVEmmanuel Elalouf, Partner, Cukierman Life SciencesRichard Seabrook, Senior Advisor, Wellcome TrustUlrich Mühlner, Founder & Managing Director, GrowthCube Partners, LLC

15:30

Last Chance to Network & Farewell Drinks16:00

End of the 10th ELSCEO Forum & Exhibition16:40

8. Skin-Deep Technologies AG9. Cytomatics10. Lumigbo11. Microsleep Diagnostic Device12. Intento13. E-Medicus14. Medicinisto AG

Presenting Order: